Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a retrospective clinical study to analyze the clinical characteristics, complications, and effects of different treatment options on long-term prognosis of severe tuberculosis patients. All cases of severe tuberculosis diagnosed between 2016 and 2021 were included in the electronic medical record system of one center, and data such as demographics, hospitalization information, clinical information, laboratory or imaging examinations, treatment plans, and outcomes were collected.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| 2-year survival rate | 2-year survival rate | 2 years |
| 2-year disability rate | 2-year disability rate | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| The number of participants with the presence of clinical symptoms | 2 years | |
| Incidence of complications in patients with different treatment regimens | Incidence of complications in patients with different treatment regimens |
Not provided
Inclusion Criteria:
For patients with severe pulmonary tuberculosis, imaging and grading diagnosis meet any of the following:
Damaged lung ≥ 1 lobe
Chest CT shows lesions in ≥3 lung lobes
Hematogenous disseminated pulmonary tuberculosis
caseous pneumonia
bronchial tuberculosis
Multiple hilar or mediastinal lymph node enlargement in primary pulmonary tuberculosis
Rifampicin-resistant, multidrug-resistant, polydrug-resistant or pan-drug-resistant tuberculosis
Combined more than 2 cavities over 8mm
Tuberculous massive hemoptysis
Pulmonary tuberculosis complicated with acute infection (including multidrug-resistant bacterial infection, fungal infection or multiple infection)
Combined with extrapulmonary tuberculosis
Intracranial tuberculosis, spinal cord and/or meningeal tuberculosis
Pleural effusion, pericardial effusion
Multiple sites of lymphatic tuberculosis or surgery is necessary
Abdominal tuberculosis, tuberculous peritonitis (ascites or multiple serous cavities)
Musculoskeletal tuberculosis
Urinary or renal tuberculosis
Adrenal tuberculosis in hypoadrenal insufficiency
Liver tuberculosis
Age and gender are not limited.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Hospitalized patients diagnosed with severe tuberculosis from the Grade A tertiary hospital in Hubei Province, China.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan | Hubei | 430030 | China | ||
Not provided
| ID | Term |
|---|---|
| D014376 | Tuberculosis |
| ID | Term |
|---|---|
| D009164 | Mycobacterium Infections |
| D000193 | Actinomycetales Infections |
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 years |
| Length of hospital stay for patients | Length of hospital stay for patients | 2 years |
| Proportion of patients admitted to the ICU | Proportion of patients admitted to the ICU | 2 years |
| Wuhan Pulmonary Hospital(Wuhan Institute for Tuberculosis Control) |
| Hubei |
| Wuhan |
| 430030 |
| China |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |